Spray-dry Formulations

Abstract

Disclosed herein are compounds, compositions, and methods for preventing and treating proliferative diseases associated with aberrant receptor tyrosine kinase (RTK) activity. The therapeutic indications described herein more specifically relate to the non-selective inhibition of RTKs associated with vascular and pulmonary disorders.


Claims
Download PDF
Document Preview
Document History
  • Publication: Mar 27, 2018
  • Application: Oct 10, 2014
    US US 201415028347 A
  • Priority: Oct 10, 2014
    US US 201415028347 A
  • Priority: Oct 10, 2014
    US US 2014/0060039 W
  • Priority: Oct 11, 2013
    US US 201361889887 P

Download Citation


Sign in to the Lens

Feedback